Back to search

Article

Adaptive landscape of the metallo-β-lactamase NDM to emerging β-lactam-based therapies

2026-07-13

Abstract excerpt

The New Delhi metallo-β-lactamase (NDM) is a major determinant of carbapenem resistance. This has prompted the development of novel therapeutic strategies to treat NDM producers. Since these therapies impose new selective pressures, their clinical deployment may favor NDM variants carrying escape mutations. To anticipate these events and inform future therapeutic decisions, we explored the evolutionary landscape o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d0efa2f-95cc-5c28-b0b3-95e61b918457
DOI
10.64898/2026.07.10.737697
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adaptive landscape of the metallo-β-lactamase NDM to emerging β-lactam-based therapiesDOI 10.64898/2026.07.10.737697
Select a neighboring publication to make it the new centre.